IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $413,439,482 | +10.3% | 9,114,627 | -0.2% | 0.01% | +20.0% |
| Q2 2023 | $374,857,219 | +16.8% | 9,136,174 | +1.7% | 0.01% | +11.1% |
| Q1 2023 | $321,025,474 | -6.4% | 8,982,246 | -1.1% | 0.01% | -18.2% |
| Q4 2022 | $342,934,868 | -13.2% | 9,079,557 | +1.6% | 0.01% | -15.4% |
| Q3 2022 | $395,240,000 | +20.9% | 8,936,062 | +1.2% | 0.01% | +30.0% |
| Q2 2022 | $326,937,000 | +4.5% | 8,831,390 | +4.6% | 0.01% | +25.0% |
| Q1 2022 | $312,761,000 | +20.4% | 8,443,843 | -1.1% | 0.01% | +14.3% |
| Q4 2021 | $259,849,000 | -4.6% | 8,539,282 | +5.2% | 0.01% | -12.5% |
| Q3 2021 | $272,339,000 | -16.5% | 8,119,853 | -0.7% | 0.01% | -11.1% |
| Q2 2021 | $326,288,000 | -26.0% | 8,179,666 | -16.6% | 0.01% | -30.8% |
| Q1 2021 | $440,995,000 | -20.0% | 9,808,562 | +0.6% | 0.01% | -27.8% |
| Q4 2020 | $551,292,000 | +37.2% | 9,750,502 | +15.2% | 0.02% | +20.0% |
| Q3 2020 | $401,681,000 | -21.2% | 8,465,407 | -2.1% | 0.02% | -25.0% |
| Q2 2020 | $510,048,000 | +32.1% | 8,650,728 | +5.9% | 0.02% | +5.3% |
| Q1 2020 | $386,180,000 | -23.9% | 8,167,940 | -2.8% | 0.02% | 0.0% |
| Q4 2019 | $507,588,000 | +1.5% | 8,402,389 | +0.6% | 0.02% | -9.5% |
| Q3 2019 | $500,297,000 | -11.6% | 8,350,799 | -5.1% | 0.02% | -12.5% |
| Q2 2019 | $565,743,000 | -8.6% | 8,802,576 | +15.5% | 0.02% | -14.3% |
| Q1 2019 | $618,644,000 | +49.1% | 7,621,572 | -0.7% | 0.03% | +33.3% |
| Q4 2018 | $414,977,000 | +7.8% | 7,676,257 | +2.9% | 0.02% | +23.5% |
| Q3 2018 | $384,955,000 | +31.0% | 7,463,257 | +5.8% | 0.02% | +21.4% |
| Q2 2018 | $293,965,000 | -3.8% | 7,054,579 | +1.8% | 0.01% | -6.7% |
| Q1 2018 | $305,489,000 | -12.9% | 6,930,346 | -0.6% | 0.02% | -11.8% |
| Q4 2017 | $350,722,000 | -1.2% | 6,972,606 | -0.4% | 0.02% | -5.6% |
| Q3 2017 | $355,077,000 | +2.3% | 7,003,491 | +2.6% | 0.02% | 0.0% |
| Q2 2017 | $347,135,000 | +31.6% | 6,823,987 | +4.0% | 0.02% | +28.6% |
| Q1 2017 | $263,704,000 | +31557.1% | 6,559,808 | +37569.7% | 0.01% | +1300.0% |
| Q4 2016 | $833,000 | +19.9% | 17,414 | -8.1% | 0.00% | 0.0% |
| Q3 2016 | $695,000 | -70.5% | 18,955 | -81.3% | 0.00% | -75.0% |
| Q2 2016 | $2,357,000 | -67.1% | 101,193 | -42.7% | 0.00% | -66.7% |
| Q1 2016 | $7,155,000 | -38.3% | 176,656 | -5.6% | 0.01% | -29.4% |
| Q4 2015 | $11,594,000 | – | 187,209 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |